What does GIMV HEALTH & CARE PARTNERS do?

GIMV HEALTH & CARE PARTNERS is registered with the CBE as active in: Activiteiten van holdings. Limited partnership, started on 26 March 2014, 1 establishment.

What is the address of GIMV HEALTH & CARE PARTNERS?

The registered office of GIMV HEALTH & CARE PARTNERS is located at Karel Oomsstraat 37, 2018 Antwerpen.

Is GIMV HEALTH & CARE PARTNERS still active?

Yes. According to the CBE (29 October 2026) GIMV HEALTH & CARE PARTNERS is active, legal situation “Normale toestand”, started on 26 March 2014.

Is GIMV HEALTH & CARE PARTNERS registered on Peppol?

Yes, GIMV HEALTH & CARE PARTNERS is registered on the Peppol network with ID 0208:0548956850.

What is the enterprise number of GIMV HEALTH & CARE PARTNERS?

The enterprise number of GIMV HEALTH & CARE PARTNERS is BE0548956850.

When was GIMV HEALTH & CARE PARTNERS founded?

GIMV HEALTH & CARE PARTNERS was founded on 26 March 2014.

Who are the directors of GIMV HEALTH & CARE PARTNERS?

According to the 2025 annual accounts, the directors of GIMV HEALTH & CARE PARTNERS are: ADVIESBEHEER GIMV HEALTH & CARE 2013 NV.

Is GIMV HEALTH & CARE PARTNERS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 March 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GIMV HEALTH & CARE PARTNERS make in 2025?

GIMV HEALTH & CARE PARTNERS posted a profit after taxes of € 2,390,325 in financial year 2025.

What is the revenue of GIMV HEALTH & CARE PARTNERS?

As a small company, GIMV HEALTH & CARE PARTNERS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -6,279,746.

GIMV HEALTH & CARE PARTNERS - Antwerpen - BE0548956850

Dossier GIMV HEALTH & CARE PARTNERS, printed on 29 October 2026 from databakkes.be/en/0548956850/gimv-health-care-partners. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

56 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

GIMV HEALTH & CARE PARTNERS from Antwerpen, company number BE0548956850, closed financial year 2025 with a result of € 2.4 million after tax. For that financial year GIMV HEALTH & CARE PARTNERS recorded a gross margin of € -6.3 million and equity of € 5.6 million. Compared with financial year 2025, the result moved from € -8 million to € 2.4 million. Profitable, and profit is growing. The buffer shrank hard: equity is 72 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 8, 2026.

What it is worth Shrank hard

€ 5.6 million

▼ 72% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 2.4 million

▲ still € 8 million loss in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 71,575

▲ 51% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 13.2 million paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

€ 7 million

▲ 272% vs 2025

Loans from banks and other lenders, long and short.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2025	Change 2025 → 2025
Gross margin	€ -477,317 Gross margin 2023: € -477,317 First fiscal year in the series	€ -376,460 Gross margin 2024: € -376,460 ▲ € 100,858 vs 2023 (€ -477,317) Favourable step	€ -389,150 Gross margin 2025: € -389,150 ▼ € 12,691 vs 2024 (€ -376,460) Unfavourable step	€ -6,279,746 Gross margin 2025: € -6,279,746 ▼ € 5.9 million vs 2025 (€ -389,150) Unfavourable step	▼ € 5.9 million
Profit after taxes	€ 6,011,433 Profit after taxes 2023: € 6,011,433 First fiscal year in the series	€ 450,022 Profit after taxes 2024: € 450,022 ▼ 93% vs 2023 (€ 6,011,433) Unfavourable step	€ -7,987,496 Profit after taxes 2025: € -7,987,496 ▼ € 8.4 million vs 2024 (€ 450,022) Unfavourable step	€ 2,390,325 Profit after taxes 2025: € 2,390,325 ▲ € 10.4 million vs 2025 (€ -7,987,496) Favourable step	▲ € 10.4 million
Equity	€ 27,650,366 Equity 2023: € 27,650,366 First fiscal year in the series	€ 28,100,388 Equity 2024: € 28,100,388 ▲ 2% vs 2023 (€ 27,650,366) Favourable step	€ 20,112,892 Equity 2025: € 20,112,892 ▼ 28% vs 2024 (€ 28,100,388) Unfavourable step	€ 5,592,021 Equity 2025: € 5,592,021 ▼ 72% vs 2025 (€ 20,112,892) Unfavourable step	▼ 72%
Total debts	€ 617,967 Total debts 2023: € 617,967 First fiscal year in the series	€ 1,570,335 Total debts 2024: € 1,570,335 ▲ 154% vs 2023 (€ 617,967) Unfavourable step	€ 1,934,630 Total debts 2025: € 1,934,630 ▲ 23% vs 2024 (€ 1,570,335) Unfavourable step	€ 7,040,255 Total debts 2025: € 7,040,255 ▲ 264% vs 2025 (€ 1,934,630) Unfavourable step	▲ 264%
Cash	€ 66,763 Cash 2023: € 66,763 First fiscal year in the series	€ 36,852 Cash 2024: € 36,852 ▼ 45% vs 2023 (€ 66,763) Unfavourable step	€ 47,376 Cash 2025: € 47,376 ▲ 29% vs 2024 (€ 36,852) Favourable step	€ 71,575 Cash 2025: € 71,575 ▲ 51% vs 2025 (€ 47,376) Favourable step	▲ 51%
Retained profit	€ 16,751,955 Retained profit 2023: € 16,751,955 First fiscal year in the series	€ 17,201,978 Retained profit 2024: € 17,201,978 ▲ 3% vs 2023 (€ 16,751,955) Favourable step	€ 9,214,481 Retained profit 2025: € 9,214,481 ▼ 46% vs 2024 (€ 17,201,978) Unfavourable step	€ -1,593,610 Retained profit 2025: € -1,593,610 ▼ € 10.8 million vs 2025 (€ 9,214,481) Unfavourable step	▼ € 10.8 million
Dividend	€ 3,396,446 Dividend 2023: € 3,396,446 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 3,396,446) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 13,198,416 Dividend 2025: € 13,198,416 Unchanged (€ 0) Unchanged
Bank debt	€ 615,189 Bank debt 2023: € 615,189 First fiscal year in the series	€ 1,485,970 Bank debt 2024: € 1,485,970 ▲ 142% vs 2023 (€ 615,189) Unfavourable step	€ 1,894,572 Bank debt 2025: € 1,894,572 ▲ 27% vs 2024 (€ 1,485,970) Unfavourable step	€ 7,040,255 Bank debt 2025: € 7,040,255 ▲ 272% vs 2025 (€ 1,894,572) Unfavourable step	▲ 272%
Balance sheet total	€ 28,268,333 Balance sheet total 2023: € 28,268,333 First fiscal year in the series	€ 29,670,724 Balance sheet total 2024: € 29,670,724 ▲ 5% vs 2023 (€ 28,268,333) Unchanged	€ 22,047,522 Balance sheet total 2025: € 22,047,522 ▼ 26% vs 2024 (€ 29,670,724) Unchanged	€ 12,632,276 Balance sheet total 2025: € 12,632,276 ▼ 43% vs 2025 (€ 22,047,522) Unchanged	▼ 43%

Key figures of GIMV HEALTH & CARE PARTNERS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GIMV HEALTH & CARE PARTNERS?

What happened at GIMV HEALTH & CARE PARTNERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 8, 2026 New annual accounts for financial year 2025: loss of € 8 million (▼ € 8.4 million vs 2024). Source: NBB ↗
Mar 26, 2014 New establishment in Antwerpen. KBO
Mar 26, 2014 Start of the company according to the CBE. KBO

In short

From € 6 million profit in 2023 to € 2.4 million profit in 2025.

Best year ever: 2023, with € 6 million profit.

Paid out € 16.6 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

VPM NV 59.6%

Ethias 29.8%

Adviesbeheer Gimv HC2013 4.4%

VDK Spaarbank NV 3%

GIMV HEALTH & CARE PARTNERS

Codex 324 Holding 17.8%

Medcare Partners 13.8%

MxG 11.9%

Behind GIMV HEALTH & CARE PARTNERS is ADVIESBEHEER GIMV HEALTH & CARE 2013 NV. The shares are held by VPM NV (59.6%), Ethias (29.8%), Adviesbeheer Gimv HC2013 (4.4%), VDK Spaarbank NV (3%), Gimv NV (2.6%) and Volksvermogen (0.6%). It owns 17.8% of Codex 324 Holding, 13.8% of Medcare Partners and 11.9% of MxG itself.

Directors

According to the 2025 annual accounts

ADVIESBEHEER GIMV HEALTH & CARE 2013 NV

Administrator-manager · represented by Koen DEJONCKHEERE

Shareholders

VPM NV

59.6%

Ethias

29.8%

Adviesbeheer Gimv HC2013

4.4%

VDK Spaarbank NV

Gimv NV

2.6%

Volksvermogen

0.6%

Participations

Codex 324 Holding

17.8%

Medcare Partners

13.8%

MxG

11.9%

Establishments

Establishment units

Physical locations of this company

Registered office

Karel Oomsstraat 37

2018 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 56 companies are registered at this address.

All companies at this address →

Gimv same network

€ 8.6 million revenue · 2025

Jan Moonen

€ 686,931 revenue · 2025

Wilson

€ 123,804 gross margin · 2025

San Michel

€ 64,813 gross margin · 2025

Immo Alfa

€ 383,148 gross margin · 2025

+51 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0548.956.850

VAT number

BE 0548.956.850

Registered office

Karel Oomsstraat 37, 2018 Antwerpen

Names & denominations

GIMV HEALTH & CARE PARTNERS

Enterprise type

Rechtspersoon

Legal form

Limited partnership

Legal situation

Normale toestand

Start date

26 March 2014

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Activiteiten van holdings

Holdings

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

GIMV HEALTH & CARE PARTNERS

Warning lights

Financials

What happened to GIMV HEALTH & CARE PARTNERS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions